Portfolio company Mars Bioimaging received U.S. FDA 510(k) clearance for its portable photon-counting CT scanner.
MARS Bioimaging is pioneering photon counting CT technology that enables clinicians to see more, diagnose earlier, and bring advanced imaging closer to patients
MARS Bioimaging is pioneering photon counting CT technology that enables clinicians to see more, diagnose earlier, and bring advanced imaging closer to patients.